Patient Guide: Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 4 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05852717
Status: 🟢 Enrolling Now
Condition: Large Cell Lymphoma, Diffuse, Relapsed Cancer, Refractory Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 4 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Indianapolis, Indiana
  • Detroit, Michigan
  • Dallas, Texas
  • • And 1 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily